Reactive oxygen species
May include species such as hydrogen peroxide and hydroxyl-related species.
COLD ATMOSPHERIC PLASMA
RONS · Skin Barrier · Microcirculation · Topical Delivery
Explore the science ↓BEGIN WITH THE BASICS
The fourth state, thoughtfully applied.
Cold atmospheric plasma brings an unusual branch of physics into skincare. By energizing a gas—often ordinary air—a device creates a partially ionized mixture containing electrons, ions, excited molecules, and reactive oxygen and nitrogen species, commonly abbreviated RONS.
Unlike technologies designed primarily around heat, light, or electrical stimulation, cold atmospheric plasma creates a complex chemical and electrical environment at the skin surface while keeping the bulk gas temperature relatively low.
The important distinction: cold plasma is not simply another name for a plasma pen, thermal plasma, radiofrequency, or laser treatment. Its effects depend on how the plasma is generated, what reactive species are produced, treatment time, distance, power, temperature, and the design of the device itself.
WHAT IS PLASMA?
From matter to plasma.
Most of us learn three familiar states of matter: solid, liquid, and gas. Add sufficient energy to a gas and some of its atoms or molecules become ionized. The resulting mixture of charged and neutral particles is known as plasma, sometimes described as the fourth state of matter.
For skincare, the important development is cold atmospheric plasma, or CAP. “Cold” does not mean the plasma is refrigerated. It means energetic electrons can drive chemical reactions while the overall gas remains at a temperature compatible with biological tissue.
NOT ALL PLASMA IS THE SAME
Cold plasma and thermal plasma are not interchangeable.
Some aesthetic plasma systems intentionally create significant heat or controlled tissue injury. Others generate a low-temperature plasma intended to interact with the skin without relying primarily on thermal destruction.
That means the word plasma alone tells us very little about a device. A consumer should know whether a system uses cold atmospheric plasma, an electrical arc, plasma-assisted radiofrequency, a plasma jet, dielectric barrier discharge, or another method entirely.
Evidence must match the technology. Research from an ablative plasma system cannot automatically be transferred to a low-temperature home-use plasma device—and vice versa.
WHAT ACTUALLY REACHES THE SKIN?
Cold plasma is not one single active ingredient.
Depending on the plasma source and operating conditions, CAP can contain a changing mixture of reactive oxygen species, reactive nitrogen species, charged particles, transient electric fields, photons, and excited molecules.
Reactive nitrogen species
May include nitric-oxide-related compounds and other nitrogen species.
Charged particles
Electrons and ions contribute to the electrical and chemical character of the plasma.
Electric fields + photons
Transient fields and light emission can contribute to the overall exposure.
HOW COLD PLASMA INTERACTS WITH SKIN
The skin surface is where the conversation begins.
When CAP encounters skin, reactive species and electrical effects can interact with water, proteins, lipids, and other molecules at or near the surface.
RONS and signaling: reactive oxygen and nitrogen species are often associated with oxidative stress when present in excess, but at controlled exposures they can also participate in normal biological signaling.
Nitric oxide and microcirculation: nitric oxide is an important signaling molecule involved in vascular function. Human research with specific CAP systems has shown temporary increases in cutaneous blood flow and tissue oxygen saturation following treatment.
The skin barrier: experimental research suggests that CAP can temporarily alter barrier properties and permeability under selected conditions.
PLASMA + SKINCARE
Can cold plasma help topical delivery?
Potentially—but this is an area where the details matter enormously. Studies using selected plasma systems have shown increased transport of certain molecules across the skin and enhanced performance of specific topical treatments.
That does not mean plasma makes every serum penetrate more deeply. Molecular size, polarity, vehicle, concentration, plasma source, exposure time, and the condition of the skin all influence delivery.
A more precise statement: cold atmospheric plasma may temporarily modify the skin surface in ways that can enhance the delivery of selected compatible topical ingredients under appropriate conditions.
WHAT THE EVIDENCE SUGGESTS
Promising science—with important boundaries.
Cold atmospheric plasma has a broad research literature spanning dermatology, wound care, microbiology, topical delivery, inflammation, and cosmetic science. The maturity of the evidence differs considerably by application.
Visible skin rejuvenation
Human and preclinical studies have reported changes involving elasticity, wrinkles, pigmentation, fibroblast activity, extracellular-matrix proteins, collagen, and epidermal architecture. These findings are encouraging, but they apply most directly to the exact systems and protocols studied.
Microcirculation
Human research with selected CAP systems has reported temporary increases in cutaneous blood flow and tissue oxygen saturation after treatment, demonstrating that cold plasma can produce measurable physiological responses.
Topical delivery
Experimental and clinical research suggests that CAP can temporarily alter skin permeability and enhance transport of selected molecules under defined conditions.
Antimicrobial research
CAP has been studied extensively for interactions with bacteria, fungi, viruses, and biofilms. Medical antimicrobial findings should not be translated directly into consumer disease-treatment claims unless the exact device has appropriate evidence and regulatory labeling.
A note on the portable-plasma study
A 2021 Scientific Reports study evaluated a portable cold-plasma device in an animal model. The investigators measured reactive species and skin temperature, then examined collagen, epidermal thickness, and mechanical skin parameters after repeated treatment. The findings are useful as mechanistic and preclinical evidence, but they are not a human clinical trial and should not be interpreted as evidence for Luvora specifically.
READING THE SPECIFICATIONS
The metrics that matter.
A technically credible cold-plasma device should disclose more than the word “plasma.” The complete treatment system matters.
| Metric | What it means | Why it matters |
|---|---|---|
| Plasma generation method | How the device creates the plasma, such as dielectric barrier discharge or plasma jet technology. | Different plasma sources can produce very different biological exposures. |
| Working gas | Air, argon, helium, nitrogen, or another gas used to form the plasma. | Gas composition changes the reactive species produced. |
| Electrical parameters | Voltage, frequency, pulse structure, and related operating conditions. | These influence discharge behavior and the resulting plasma chemistry. |
| Treatment distance | Distance between plasma source and skin. | Small changes in geometry can change the exposure reaching the skin. |
| Treatment time | Duration of exposure to one area. | Plasma effects are dose-dependent; more is not automatically better. |
| Surface temperature | Temperature reached during treatment. | Helps distinguish low-temperature plasma interaction from thermal treatment. |
| Reactive species / ozone | Chemical species generated during operation. | These can be central to both biological activity and safety. |
| Coverage and uniformity | How evenly plasma is delivered across the intended area. | A headline output value does not tell us whether treatment is uniform. |
SAFETY + RESPONSIBLE USE
Cold does not mean biologically inactive.
Cold atmospheric plasma is designed to reduce the thermal burden associated with hotter plasma technologies, and multiple studies have reported good skin tolerability under defined conditions.
But reactive species, electric fields, ultraviolet emission, ozone, temperature, and treatment geometry all depend on the system and exposure.
- Follow the manufacturer’s treatment time, movement technique, distance, and contraindications.
- Do not assume that longer or more frequent treatment will improve results.
- Avoid areas or conditions excluded by the device labeling.
- Seek qualified medical guidance for suspicious lesions, active disease, severe inflammation, or uncertain suitability.
- Stop use if treatment causes an unexpected or persistent adverse response.
Regulatory integrity matters. Registration, listing, clearance, and approval do not mean the same thing. Claims for a marketed device should match its exact evidence and regulatory status.
THE PROAGING STANDARD
How we evaluate a cold-plasma device.
A futuristic mechanism is not enough. We look for a coherent relationship among the plasma-generation technology, output specifications, treatment protocol, safety controls, published evidence, intended use, and real-world user experience.
Purpose
What is the device designed to do, and is that use clearly defined?
Plasma source
Does the manufacturer identify how the plasma is generated and what gas or discharge system is used?
Output
Are meaningful electrical, temperature, treatment-distance, and exposure specifications disclosed?
Protocol
Are treatment time, movement, spacing, frequency, and compatible skincare clearly defined?
Evidence
Do the claims align with research using comparable technology and exposure conditions?
Safety
Are temperature, materials, ozone, electrical safety, contraindications, and foreseeable misuse addressed?
Our standard: can the consumer understand what the technology is actually doing?
FREQUENTLY ASKED QUESTIONS
Cold plasma, clarified.
Is cold plasma the same as a plasma pen?
No. “Plasma” describes a broad technology category. Cold atmospheric plasma is designed to create biologically active plasma while maintaining relatively low bulk temperatures. Devices that create an electrical arc or intentionally heat or ablate tissue can behave very differently.
Is cold plasma the same as radiofrequency?
No. Radiofrequency uses electromagnetic energy and typically generates controlled heating through electrical resistance or impedance. CAP creates an ionized gas containing reactive species, charged particles, electric fields, and other components.
Is cold plasma the same as LED therapy?
No. LED photobiomodulation primarily uses selected wavelengths of light. CAP is a plasma-based system whose effects involve reactive species, charged particles, electric fields, and other plasma-generated components.
Does cold plasma penetrate deeply into the skin?
That description is too simplistic. Much of the interaction begins at the skin surface. Longer-lived reactive products and downstream biological signaling can extend the response beyond the immediate surface, but the extent depends on the plasma source, tissue, species involved, dose, and treatment geometry.
Can I apply serum after plasma?
Some plasma technologies are specifically studied for topical-delivery enhancement, but only products compatible with the individual device should be used. Follow the manufacturer’s instructions for skincare pairing and timing.
Does more plasma mean better results?
No. CAP exhibits dose-dependent biological behavior. An appropriate exposure may support useful signaling, while excessive oxidative exposure could be counterproductive. Treatment protocol matters.
A MORE THOUGHTFUL RELATIONSHIP WITH TECHNOLOGY
The future of beauty technology should be understandable.
Cold atmospheric plasma feels futuristic—and in many ways it is. But what makes the technology compelling is not the spectacle of ionized gas. It is the possibility of precisely controlling a complex interaction among physics, chemistry, and biology.
At Proaging Technology, we believe emerging technologies deserve more scrutiny, not less. We look beyond the word plasma to understand the source, the dose, the treatment geometry, the evidence, and the actual intended use.
The future of beauty technology should not simply look advanced. It should be understandable.
SOURCES & FURTHER READING
Explore the underlying science.
These resources are intended as accessible starting points for readers who wish to explore cold atmospheric plasma in greater depth. Findings from one plasma source or treatment protocol should not be assumed to apply to every consumer device.
Cold Atmospheric Plasma (CAP): A Revolutionary Approach in Dermatology and Skincare
A 2024 review examining CAP, reactive oxygen and nitrogen species, dermatologic applications, skincare research, mechanisms, safety, and emerging clinical uses.
View source →Cold Atmospheric Plasma Ameliorates Skin Diseases Involving Reactive Oxygen/Nitrogen Species-Mediated Functions
A 2022 review discussing RONS and biological pathways being investigated in plasma dermatology.
View source →Penetration Depth of Cold Atmospheric Plasma Into Biological Tissue: A Review
A review examining how plasma-generated species interact with biological tissue and the factors influencing penetration depth.
View source →Improvement of Cutaneous Microcirculation by Cold Atmospheric Plasma
A prospective human study evaluating CAP effects on cutaneous blood flow and tissue oxygen saturation in healthy volunteers.
View source →Analgesic Effect of Topical Lidocaine Is Enhanced by Cold Atmospheric Plasma Pretreatment
A randomized split-face human study investigating CAP pretreatment as a method of enhancing transdermal delivery of topical anesthetic.
View source →Efficacy of Low-Temperature Plasma for Treatment of Facial Rejuvenation in an Asian Population
A prospective clinical study evaluating objective and clinical measures after a series of low-temperature plasma facial treatments.
View source →Cold Plasma Is Well-Tolerated and Does Not Disturb Skin Barrier or Reduce Skin Moisture
An early human tolerability study examining transepidermal water loss, skin moisture, and short-term barrier response after treatment with several cold-plasma sources.
View source →Cold Atmospheric Plasma: A Promising and Safe Therapeutic Strategy for Atopic Dermatitis
A scientific review discussing cold plasma, reactive species, skin-barrier biology, lipid interactions, and research involving skin permeability.
View source →In Vivo Study of the Effects of a Portable Cold Plasma Device and Vitamin C for Skin Rejuvenation
A 2021 preclinical animal study examining a portable plasma device, reactive species, treatment temperature, collagen, epidermal thickness, and mechanical skin parameters. It should not be interpreted as clinical evidence for Luvora or any other specific consumer device.
View source →Cold Atmospheric Plasma Therapy for Malassezia Folliculitis
A 2024 randomized clinical study exploring antifungal activity, clinical performance, and tolerability of a specific CAP protocol.
View source →A note on interpreting the research: cold atmospheric plasma is a broad technology category. Plasma source, treatment geometry, reactive-species output, electrical parameters, temperature, treatment time, and intended use can differ substantially between devices.
CLARITY BEFORE COMMITMENT
Good technology starts with good questions.
Explore the science, specifications, and instructions with your goals in mind. For suitability or a skin condition, speak with a qualified health professional.
